Rankings
▼
Calendar
ARVN FY 2017 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena
ARVN
Arvinas, Inc.
$856M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$8M
+13.6% YoY
Gross Profit
$8M
100.0% margin
Operating Income
-$25M
-326.7% margin
Net Income
-$24M
-317.3% margin
EPS (Diluted)
$-1.38
Cash Flow
Operating Cash Flow
$5M
Free Cash Flow
$4M
Stock-Based Comp.
$245,048
Balance Sheet
Total Assets
$67M
Total Liabilities
$67M
Stockholders' Equity
$245,870
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$8M
$7M
+13.6%
Gross Profit
$8M
$7M
+13.6%
Operating Income
-$25M
-$16M
-50.3%
Net Income
-$24M
-$14M
-67.6%
← FY 2016
All Quarters
Q1 2017 →